Amgen Ties Increased Transfusions To ESA Scrutiny in NCD Review Request
Executive Summary
Amgen has released an internally generated analysis of data that draws a causal link between an increase in blood transfusions and the heightened scrutiny erythropoiesis-stimulating agents have received this year